Physician profile
Paul Diggs
NPI 1417919549
$778.76
in general payments reported to CMS, 2019-2025
6 companies · $52.31 in 2025
The $52.31 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $21.69 · 2023: $125 · 2024: $330 · 2025: $52.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $302.94 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $284.07 | 2021-2025 | Aveir, Mitraclip, Jot Dx |
| Boston Scientific Corporation | $115.71 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Tactile Systems Technology INC | $39.29 | 2024 | Entre Plus, Flexitouch Plus |
| Preventice Services, LLC | $28.21 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.54 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Diggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.